| NDC Code | 67767-133-25 |
|---|
| Package Description | 250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67767-133-25) |
|---|
| Product NDC | 67767-133 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Bupropion Hydrochloride |
|---|
| Non-Proprietary Name | Bupropion Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20080312 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA077455 |
|---|
| Manufacturer | Actavis South Atlantic LLC |
|---|
| Substance Name | BUPROPION HYDROCHLORIDE |
|---|
| Strength | 150 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
|---|